tilelimumab
Showing 1 - 1 of 1
Tislelizumab, Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment Trial in Changchun (Tilelimumab)
Not yet recruiting
- Tislelizumab
- +3 more
- Tilelimumab
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
May 26, 2021